About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiology research group of the Vall d'Hebron Research Institute (VHIR) focuses on the study of microbiological aspects —in basic, translational and clinical research— that could improve the outcome of patients with infectious diseases.
Our priority research areas are:
We actively collaborate with other microbiology laboratories, health services, national and international centres and organizations, as well as with the different research networks of the Carlos III Health Institute in Spain.
In addition, we carry out an important activity in the surveillance of the genotypic and phenotypic evolution of microorganisms present in the community in terms of their virulence, transmissibility, antigenic escape and antimicrobial resistance, in collaboration with public administrations, both at the national and international level.
PMID: 31955099 Journal: SCIENCE OF THE TOTAL ENVIRONMENT Year: 2020 Reference: Sci Total Environ. 2020 Apr 15;713:136604. doi: 10.1016/j.scitotenv.2020.136604. Epub 2020 Jan 8. Impact factor: 6.551 Publication type: Paper in international publication Authors: Martinez-Puchol, Sandra, Rusinol, Marta, Fernandez-Cassi, Xavier, Timoneda, Natalia, Itarte, Marta, Andres, Cristina, Anton, Andres, Abril, Josep F, Girones, Rosina, Bofill-Mas, Silvia et al. DOI: 10.1016/j.scitotenv.2020.136604
PMID: 31941694 Journal: JOURNAL OF CLINICAL MICROBIOLOGY Year: 2020 Reference: J Clin Microbiol. 2020 Mar 25;58(4). pii: JCM.01886-19. doi: 10.1128/JCM.01886-19. Print 2020 Mar 25. Impact factor: 5.897 Publication type: Paper in international publication Authors: Fernandez-Naval, Candela, Barbera, Maria-Jesus, Aparicio, David, Pich, Oscar Q, Pumarola, Tomas, Jensen, Jorgen S, Espasa, Mateu, Moreno-Mingorance, Albert, Esperalba, Juliana, Serra-Pladevall, Judit et al. DOI: 10.1128/JCM.01886-19
PMID: 31940096 Journal: Annals of Intensive Care Year: 2020 Reference: Ann Intensive Care. 2020 Jan 15;10(1):7. doi: 10.1186/s13613-020-0625-5. Impact factor: 4.124 Publication type: Paper in international publication Authors: Baldira, Jaume, Ruiz-Rodriguez, Juan Carlos, Wilson, Darius Cameron, Ruiz-Sanmartin, Adolf, Cortes, Alejandro, Chiscano, Luis, Ferrer-Costa, Roser, Comas, Inma, Larrosa, Nieves, Fabrega, Anna et al. DOI: 10.1186/s13613-020-0625-5
PMID: 31701864 Journal: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE Year: 2020 Reference: Am J Trop Med Hyg. 2020 Jan;102(1):159-163. doi: 10.4269/ajtmh.19-0550. Impact factor: 2.126 Publication type: Paper in international publication Authors: Molina, Israel, Silgado, Aroa, Moure, Zaira, Bosch-Nicolau, Pau, Salvador, Fernando, Sanchez-Montalva, Adrian, Martinez-Gallo, Monica, Sulleiro, Elena, Franco-Jarava, Clara, Sao Aviles, Augusto et al. DOI: 10.4269/ajtmh.19-0550
PMID: 30525470 Journal: ACS Sensors Year: 2019 Reference: ACS Sens. 2019 Jan 25;4(1):52-60. doi: 10.1021/acssensors.8b00789. Epub 2018 Dec 20. Impact factor: 6.944 Publication type: Paper in international publication Authors: Dey, Priyanka, Fabri-Faja, Nuria, Calvo-Lozano, Olalla, Terborg, Roland A, Belushkin, Alexander, Yesilkoy, Filiz, Fabrega, Anna, Ruiz-Rodriguez, Juan Carlos, Ferrer, Ricard, Gonzalez-Lopez, Juan Jose et al. DOI: 10.1021/acssensors.8b00789
PMID: 30674377 Journal: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE Year: 2019 Reference: Int J Tuberc Lung Dis. 2019 Jan 1;23(1):67-72. doi: 10.5588/ijtld.18.0231. Impact factor: 2.024 Publication type: Paper in international publication Authors: Gabriel, E, Aznar, M L, Rando-Segura, A, Moreno, M M, Soley, M E, Igual, E S, Bocanegra, C, Olivas, E G, Eugenio, A Ninda, Zacarias, A et al. DOI: 10.5588/ijtld.18.0231
PMID: 28549036 Journal: APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY Year: 2019 Reference: Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):77-80. doi: 10.1097/PAI.0000000000000533. Impact factor: 1.863 Publication type: Paper in international publication Authors: Castellvi, Josep, Moure, Zaira, Tortola, M Teresa, Pumarola, Tomas, Sanchez-Montalva, Adrian et al. DOI: 10.1097/PAI.0000000000000533
PMID: 30537648 Journal: JOURNAL OF CLINICAL VIROLOGY Year: 2019 Reference: J Clin Virol. 2019 Jan;110:45-50. doi: 10.1016/j.jcv.2018.11.010. Epub 2018 Dec 1. Impact factor: 3.02 Publication type: Paper in international publication Authors: Len, Oscar, Perello, Manel, Torres, Irina B, Codina, Gemma, Esperalba, Juliana, Sellares, Joana, Moreso, Francesc, Seron, Daniel, Gavalda, Joan, Los-Arcos, Ibai et al. DOI: 10.1016/j.jcv.2018.11.010
The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.
The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.
The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.
